...
首页> 外文期刊>Pulmonary pharmacology & therapeutics >Promoting effects of IL-13 on Ca~(2+) release and store-operated Ca~(2+) entry in airway smooth muscle cells
【24h】

Promoting effects of IL-13 on Ca~(2+) release and store-operated Ca~(2+) entry in airway smooth muscle cells

机译:IL-13对气道平滑肌细胞中Ca〜(2+)释放和操纵性Ca〜(2+)进入的促进作用

获取原文
获取原文并翻译 | 示例
           

摘要

Th2 cytokine interleukin (IL)-13 plays a central role in the pathogenesis of allergic asthma. IL-13 exhibits a direct effect on airway smooth muscle cells (ASMCs) to cause airway hyperresponsiveness. IL-13 has been demonstrated to regulate Ca~(2+) signaling in ASMCs, but the underlying mechanisms are not fully understood. Store-operated Ca~(2+) entry (SOCE) plays an important role in regulating Ca~(2+) signaling and cellular responses of ASMCs, whether IL-13 affects SOCE in ASMCs has not been reported. In this study, by using confocal Ca~(2+) fluorescence imaging, we found that IL-13 (10 ng/ml) treatment increased basal intracellular Ca~(2+) ([Ca~(2+)]j) level, Ca~(2+) release and SOCE induced by SERCA inhibitor thapsigargin in rat r bronchial smooth muscle cells. The glucocorticoid dexamethasone and the short-acting fS2 adrenergic agonist (32 agonist) salbutamol suppressed IL-13-augumented basal [Ca~(2+)]j, Ca~(2+) release and SOCE, whereas the long-acting |32 agonist salmeterol had no effect on altered Ca~(2+) signaling in IL-13-treated ASMCs. Membrane-permeable cAMP analog dibutyryl-cAMP (db-cAMP) similarly decreased Ca~(2+) release and SOCE induced by thapsigargin in IL-13-treated ASMCs, confirmed a role of cAMP/PKA signaling pathway in the regulation of SOCE. IL-13 promoted the proliferation of ASMCs stimulated by serum; this effect was inhibited by nonspecific Ca~(2+) channel blockers SKF-96365 and NiCb, by salmeterol, but not by salbutamol and dexamethasone. IL-13 treatment did not change the expression of SOC channel-associated molecules STIM1, Orail and TRPC1 at mRNA level. Our findings identified a promoting effect of IL-13 on Ca~(2+) release and SOCE in ASMCs, which partially contributes to its effect on the proliferation of ASMCs; the differences of glucocorticoids and {32 agonists in inhibiting Ca~(2+) signal and proliferation potentiated by IL-13 suggest that these therapies of asthma may have distinct effect on the relief of airway contraction and remodeling in bronchial asthma.
机译:Th2细胞因子白介素(IL)-13在过敏性哮喘的发病机理中起着核心作用。 IL-13对气道平滑肌细胞(ASMC)表现出直接作用,导致气道高反应性。 IL-13已被证明可调节ASMC中的Ca〜(2+)信号传导,但其潜在机制尚不完全清楚。贮藏操作的Ca〜(2+)进入(SOCE)在调节ASMC的Ca〜(2+)信号和细胞应答中起重要作用,但尚未报道IL-13是否影响ASMC中的SOCE。在这项研究中,通过使用共聚焦Ca〜(2+)荧光成像,我们发现IL-13(10 ng / ml)处理可提高基础细胞内Ca〜(2+)([Ca〜(2 +)] j)的水平SERCA抑制剂thapsigargin诱导大鼠支气管平滑肌细胞Ca〜(2+)释放及SOCE的变化。糖皮质激素地塞米松和短效fS2肾上腺素激动剂(32激动剂)沙丁胺醇抑制IL-13增强的基础[Ca〜(2 +)] j,Ca〜(2+)释放和SOCE,而长效| 32种激动剂沙美特罗对经IL-13处理的ASMC中Ca〜(2+)信号转导没有影响。膜通透性cAMP类似物二丁酰-cAMP(db-cAMP)同样降低了thapsigargin在IL-13处理的ASMC中诱导的Ca〜(2+)释放和SOCE,证实了cAMP / PKA信号通路在调节SOCE中的作用。 IL-13促进血清刺激的ASMC增殖。非特异的Ca〜(2+)通道阻滞剂SKF-96365和NiCb,沙美特罗可抑制这种作用,沙丁胺醇和地塞米松则不会。 IL-13处理在mRNA水平上未改变SOC通道相关分子STIM1,Orail和TRPC1的表达。我们的发现确定了IL-13对ASMC中Ca〜(2+)释放和SOCE的促进作用,部分有助于其对ASMC增殖的影响。糖皮质激素和{32激动剂在抑制Ca〜(2+)信号和IL-13增强的增殖方面的差异表明,这些哮喘疗法可能对缓解支气管哮喘的气道收缩和重塑具有明显的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号